Biopsy specimens were obtained from 102 leprosy patients before chemotherapy and examined by polymerase chain reaction (PCR) using the primers amplifying the 372-bp DNA of a repetitive sequence of Mycobacterium leprae. The PCR results were then compared with bacterial indices (BI) of slit-skin smears and biopsy specimens. The intensities of DNA bands were in general correlated with the numbers of acid-fast bacilli, and even a sample with only one organism gave a PCR positive result. Ten 5-p,m sections from each frozen tissue sample were pooled and processed for DNA preparation. PCR was positive for 11 (73.3%) of 15 biopsy specimens with BI of 0 determined for the paraffin sections from the same biopsy samples. PCR also gave positive results for 84 (96.6%) of 87 BI positive biopsy samples. Although the difference in overall results between the two methods was not statistically significant, PCR seemed to have an advantage over microscopic examination in detecting M. keprae in biopsy specimens negative for acid-fast bacilli. Further evaluation of PCR using more specimens from leprosy patients who are bacteriologically negative is warranted to ensure PCR's advantage over the conventional microscopic examination for the diagnosis of leprosy.
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The recent development of polymerase chain reaction (PCR) has brought an unprecedented opportunity for sensitive, specific, and rapid detection of Mycobactenum leprae in clinical specimens. In the literature, there have been various target sequences for PCR and DNA probes specific for M. leprae, such as genes encoding the 36-kDa antigen (2, 6) , the 18-kDa antigen (10) , or the 65-kDa antigen (8) and repetitive sequences of M. leprae (11, 12) . Most of the reports showed that PCR with or without DNA probes seemed very sensitive, so that even 1 to 100 organisms are detectable by the method. In addition, PCR provided virtually 100% specificity in detecting the organism in clinical samples.
However, PCR tools have not been fully evaluated for detecting M. leprae in clinical specimens from leprosy patients. In a study with biopsy specimens from leprosy patients, PCR gave a positive result in about 61% of biopsies from leprosy patients negative for acid-fast bacilli (AFB) (2) , thus indicating that PCR is a useful tool for the laboratory diagnosis of leprosy. No information about PCR based on other target sequences and protocols was available. In this study, therefore, we attempted to evaluate PCR using primers (11, 12) amplifying 372 bp of the repetitive sequence of M. leprae (4) in frozen sections of biopsy specimens from untreated leprosy patients, and the results were then compared with microscopic findings. paraffin embedding, and the other half was stored at -20°C until used for PCR. Bacterial indices (BI) were then determined microscopically for paraffin sections of biopsy specimens. For each patient, slit-skin smears from three or six sites depending on the clinical type of leprosy were prepared also, as described previously (13) . The BI of each slit-skin smear was determined by microscopic examination, and the average BI was then calculated for each patient before analysis. Tissue samples from persons with dermatologic problems other than leprosy also were included as controls.
MATERIALS AND METHODS
Preparation of M. kprae DNAs from biopsy specimens. Frozen biopsy specimens were cut 5 ,um thick by using disposable blades in a cryostat microtome. Ten sections from each biopsy specimen were put into a conical screwcapped vial and prepared for repeated experiments if necessary. In order to purify DNA from M. leprae, a bead-beating method described by Plikaytis et al. (8) was employed with minor modifications. Briefly, to each vial containing 10 frozen sections a 100-,u volume of 0.1-mm zirconium beads (Biospec Products, Bartlesville, Okla.) in Tris-EDTA (pH 7.4) was added, and the residual soup was removed after the beads settled. To the tube, 100 p,l of Tris-EDTA-NaCl (pH 8.0) and 50 ,ul of phenol-chloroform-isoamyl alcohol (25: 24:1) were added, and the tube was shaken vigorously for 1 min by using a bead beater (Biospec Products). After centrifugation for 5 min, the aqueous phase was collected and mixed with an equal volume of chloroform-isoamyl alcohol (24:1). After another brief centrifugation, the upper phase was collected and boiled for 10 min to destroy DNase, and DNA was then precipitated with ethanol. The precipitated DNA was resuspended in 10 p,l of distilled water and used for PCR.
Amplification of M. leprae DNA by PCR. The primers amplifying the 372 bp (11, 12) 2 min, and primer extension at 72°C for 3 min. After purified DNA was added to the PCR mix, the tubes were kept for at least 10 min at room temperature, and the first denaturation time was extended to 11 min to ensure the destruction of UTP-containing amplified products from the previous experiments. After amplification was finished, a 40-,ul portion of the reaction mixture was run in an 8% polyacrylamide gel. After electrophoresis, the gel was stained with ethidium bromide, and the 372-bp DNA band was examined under UV illumination. Corynebacterium diphtheriae) were used for PCR. The 372-bp DNA was amplified by PCR only in DNA from M. leprae and not in DNA from other mycobacterial species or bacteria belonging to other genera which were examined in this study. In addition, the amplified 372-bp DNA was detectable by PCR in biopsy specimens from leprosy patients but not in specimens from five other dermatologic patients. This study thus indicated that the 372-bp DNA amplified with primers Rl and R2 is specific to M. leprae.
RESULTS

Specificity
The sensitivity of the primers was determined by amplification of the 372-bp DNA from a series of dilutions of a mouse footpad suspension whose AFB count was determined microscopically as described by Shepard and McRae (9) . As shown in Fig. 1 , DNA purified from a vial which was supposed to contain only one AFB showed a faint but clear 372-bp DNA band after amplification by PCR. The intensities (thickness) of the 372-bp DNA bands increased in a dose-response fashion as AFB numbers increased from 1 to 103.
Detection of M. kprae DNA in biopsy specimens from leprosy patients by PCR. Biopsy specimens from leprosy patients were examined for the presence of M. leprae by PCR using primers Rl and R2 (11, 12) . DNAs were purified from 10 frozen sections from each biopsy specimen, and all of the DNAs were used in one reaction. Figure 2 shows some of the PCR results for biopsy samples from leprosy patients. As expected, biopsy specimens from patients with high BI showed strong 372-bp bands (Fig. 2, lanes 16 to 18) . In certain samples, however, the 372-bp DNA was not ampli- Since the average BI obtained from slit-skin smears is more readily available and more relevant to the assessment of leprosy patients for diagnosis, the PCR results of biopsy specimens were also compared with the average BI in slit-skin smears of leprosy patients before the initiation of treatment. Of 10 biopsy specimens from patients whose average BI was 0 in slit-skin smears, 6 (60.0%) clearly showed the 372-bp DNA band by PCR, indicating the presence ofM. leprae (Table 3) . Meanwhile, 18 (90.0%) of 20 specimens from patients with an average BI of 0.1 to 0.9 and 4 (80.0%) of 5 specimens from patients with an average BI of 1.0 to 1.9 were PCR positive. The 372-bp DNAs were amplified by PCR for all biopsy specimens from 67 patients with an average BI of 2.0 or above in slit-skin smears. Again, PCR performed with biopsy specimens was superior to slit-skin smear examination for the detection of M. leprae in leprosy patients with BI of 0.
When only high-BI slit-skin smears or biopsy specimens from each patient were chosen for analysis, only 4 of 102 patients had BI of 0 for both slit-skin smears and biopsy specimens. Of the specimens from the four patients, one was PCR positive and the others were PCR negative ( biopsy specimens of leprosy patients. The repetitive sequence, part of which was used as the target DNA for amplification by PCR in this study, was reported to be specific to M. leprae and was not present in 20 mycobacterial species other than M. leprae or in other bacterial species including leprosy-associated Corynebacterium species in hybridization analysis (4) . Therefore, the 372-bp DNA products amplified by PCR using primers Rl and R2, originally designed by Woods and Cole (11, 12) , should be derived only from M. leprae. This was confirmed in our study, which showed that the 372-bp DNA product was amplified only from M. leprae and not from 5 other mycobacterial species, 10 other bacteria, or five skin tissues from patients with various dermatologic diseases (data not shown). Therefore, this procedure provides an advantage of not requiring hybridization using a DNA probe or any other step to confirm that the 372-bp DNA product is specific to M. leprae, which was often used for PCR with M. leprae (2, 8) and M. tuberculosis (5, 7) .
In addition, the use of the repetitive sequence as a PCR target DNA provides an advantage of higher sensitivity over other targets in the DNA, because it is present at multiple sites in a genomic DNA. Woods and Cole (12) showed that at least 28 copies of a repetitive sequence are present in an M. leprae DNA and PCR products targeting the repetitive sequence appeared six cycles earlier than those targeting a (11, 12) , it was suggested that one AFB might give a PCR positive result on the basis of about 15-to 20-fold-higher sensitivity of these primers compared with that of primers targeting the groEL gene, which showed a PCR positive result for a sample containing 20 organisms. Therefore, the PCR positive results from a sample containing one AFB obtained in this study were not surprising. This sensitivity seemed far superior to that of PCR using primers targeting other sites of M. leprae DNA, which required 10 to 100 M. leprae organisms to show amplified DNA bands (6, 8, 10) .
Under the PCR conditions, frozen sections of biopsy specimens were analyzed for the presence of M. leprae, and the results were then compared with the BI of the biopsy specimens and the average BI of slit-skin smears. Since bacteriological findings for biopsy specimens were not always matched with the BI of slit-skin smears, PCR results should be correlated better with the BI of each biopsy specimen, a portion of which was used in PCR. In this study, more than 70% of biopsy samples with no detectable AFB by microscopic examination showed amplification of the 372-bp DNA of M. leprae. De Wit et al. (2) also reported that about 60 to 80% of specimens with no AFB detected by microscopic examination had PCR positive results, although slitskin smear information for patients whose biopsy specimens were BI negative was not available. With that report and our results together, it seemed apparent that PCR is more sensitive in detecting M. leprae in biopsy specimens with no or low bacterial loads than the conventional microscopic examination.
In order to apply PCR technology for the diagnosis of leprosy in clinical settings, however, a more careful evaluation of PCR results compared with conventional microscopic examination seemed very important. In our study, 10 of 11 patients with BI of 0 but with PCR-positive biopsy specimens were in fact slit-skin smear positive (data not shown). Likewise, five of six biopsy samples from patients with slit-skin-smear-negative but PCR-positive results had AFB detectable by microscopic examination. Of 32 patients with the average BI of less than 2.0, there were 15 patients with BI-negative biopsy results and 10 patients with negative slit-skin smear results. However, only four of them were BI negative by both the slit-skin smear examination and the biopsy examination, and only one (25.0%) of the four specimens was PCR positive for M. leprae. Since PCR was not done on slit-skin smear samples, it might be difficult to compare the slit-skin smear findings with PCR results for biopsy samples. But biopsy specimens from 3 of 98 patients with confirmed presence of bacteria did not show amplification of the 372-bp DNA in repeated PCR runs. In this study, therefore, the advantage of PCR over conventional microscopic examination could not be fully demonstrated, partly because of a relatively small number of specimens with BI of 0, despite the fact that PCR was far more sensitive than microscopic examination in terms of absolute numbers of AFB detected and in terms of detecting M. leprae in biopsy samples. The results might indicate that the sensitivity achievable by PCR in the detection of M. leprae for the diagnosis of leprosy could be attained if maximum efforts to examine microscopically both slit-skin smears and biopsy specimens were made. Further study on equal numbers of BI-positive and -negative specimens will address the usefulness of PCR as a supplementary diagnostic tool for leprosy.
Of note was the fact that some of the biopsy specimens that were BI positive showed no amplification of M. leprae DNA in repeated tests. The presence of inhibitors in sputum specimens was not uncommon with PCR amplification of M. tuberculosis DNA (1, 3) . It was also noted that there were some interferences in PCR for detection of M. leprae in human tissue homogenates spiked with the organisms (10). De Wit et al. (2) showed that several biopsy specimens with BI positivity by microscopic examination did not show an amplification of M. leprae DNA by PCR. In our study, 10 frozen sections were used in a PCR run. Since the BI of these specimens (except the one with a BI of 5) were 1 to 2, there is a chance that there was no M. leprae in the 10 sections used for PCR at the beginning. In addition, there might be some technical limitations on the detection of M. leprae DNA due to PCR inhibitors, point mutations at the binding site for primers, or other PCR procedures adopted in this study. This study, therefore, showed some limitations of PCR for the detection of M. leprae in tissue specimens from leprosy patients.
In clinical practice, it may not be necessary to run PCR on BI-positive biopsy samples. Rather, the results here suggest that PCR is useful for detecting M. leprae in clinical samples in which no AFB are detectable by microscopic examination. Further evaluation of PCR is desirable for the diagnosis of leprosy, particularly with BI-negative specimens.
